Skip to main content

Illinois IGB

Martin Burke

15 Years of IGB: SHIELDing the Illinois community against COVID-19

May 11, 2022

During the earliest months of 2020, COVID-19 seemed like an innocuous event that was too geographically distant to affect the Illinois community. In fact, by March 10th there were only 19 confirmed cases. Nevertheless, Nigel Goldenfeld (BCXT leader/GNDP), former Swanlund Endowed Chair and professor of physics, and Sergei Maslov (BCXT/CABBI), a professor of bioengineering and Bliss Faculty Scholar, were worried. The news from China and Italy was concerning and in four days a significant portion of students, faculty, and staff were going to leave for spring break.


May 11, 2022


Related Articles

New set of chemical building blocks makes complex 3D molecules in a snap

February 9, 2022

A new set of molecular building blocks aims to make complex chemistry as simple and accessible as a toy construction kit.

Researchers at the University of Illinois Urbana-Champaign and collaborators at Revolution Medicines Inc. developed a new class of chemical building blocks that simply snap together to form 3D molecules with complex twists and turns, and an automated machine to assemble the blocks like a 3D printer for molecules.


February 9, 2022


Related Articles

Atomic structure of antifungal drug confirms unusual mechanism

December 13, 2021

Advanced molecular imaging technology has now mapped the structure of a drug widely used to treat fungal infections but whose workings have mystified researchers and physicians for nearly 70 years.

In a new study, researchers at the University of Illinois Urbana-Champaign, the University of Wisconsin, Madison and the National Institutes of Health described in atomistic detail the structure of the drug amphotericin B, a powerful but toxic antifungal agent.


December 13, 2021


Related Articles

10 IGB members receive Presidential Medallion

August 23, 2021

August 23, 2021


Related Articles

K-12 Shield Playbook offers guidance for reopening schools

April 15, 2021

A new resource is available to help guide teachers and school administrators as they reopen schools amid the ongoing COVID-19 pandemic, assembled by researchers and experts at the University of Illinois Urbana-Champaign. 

As vaccines for the virus that causes COVID-19 become more accessible, more communities and schools are reopening. However, no vaccines have been approved for children under 16 to date, leaving school districts with many questions to navigate as they reopen and plan for the 2021-22 school year.


April 15, 2021


Related Articles

Antifungal drug improves key cystic fibrosis biomarkers in clinical study

December 19, 2020

A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign and the University of Iowa found.

Cystic fibrosis is caused by a missing or defective ion channel in the lining of the lungs, called CFTR. This leaves patients vulnerable to lung infections. Treatments called modulators can help some but not all patients, based on which type of genetic mutation causes the symptoms.


December 19, 2020


Related Articles

Chancellor, Provost offer reflections on 1 million COVID-19 tests

December 15, 2020

It sometimes seems a million doesn’t command quite the same attention that it used to. It isn’t mathematically special. And in today’s society, it isn’t even unusually large. We now live in a world where the population is measured in billions, economies are scaled in trillions and computer calculations are counted by the quadrillion.

But it takes on a very special significance when you’re talking about looking after the well-being of your community in the middle of a globally devastating pandemic.


December 15, 2020


Related Articles

Volunteers at Illinois produce supplies for 200,000 COVID-19 tests

July 6, 2020

A collaborative effort at the University of Illinois to support COVID-19 testing is winding down, but not before it produced enough materials to support some 200,000 coronavirus tests across the state.


July 6, 2020


Related Articles

Cystic fibrosis treatment uses 'molecular prosthetic' for lung protein

March 19, 2019

An approved drug normally used to treat fungal infections could also do the job of a protein channel that is missing or defective in the lungs of people with cystic fibrosis, operating as a prosthesis on the molecular scale, says new research from the University of Illinois and the University of Iowa.


March 19, 2019


Related Articles

Subscribe to Martin Burke